Alzheimer’s Research UK and Scottish Government announce joint funding call
Scottish dementia research to benefit from £450,000 funding boost
Leave a reply
Author Archives: admin
Potential new Alzheimer’s drug passes phase 2 trials
American Academy of Neurology Conference: Safety and efficacy of ORM-12741 on cognitive and behavioural symptoms in patients with Alzheimer’s disease: A randomized, double-blind, placebo-controlled, parallel group, multicenter, proof-of-concept 12-week study.
Blood pressure drugs to slow Alzheimer’s – new clinical trial launched
A new clinical trial is being launched to test a common blood pressure drug for the treatment of Alzheimer’s. The trial, known as RADAR, is being funded by a £2m investment from the Medical Research Council (MRC) and will see around 230 participants being treated with the drug losartan.
Treatment window thrown open for Alzheimer’s
A team of US scientists has identified a critical time window of 15 years where treatments targeting the hallmark Alzheimer’s protein amyloid might have a greater effect. The study, published in Neurology, adds to evidence that early treatment in the diseases that cause dementia holds real hope for checking their destructive course.
Potential Alzheimer’s treatment moves a step closer
A new drug aimed at preventing the early stages of Alzheimer’s disease has been created by scientists at Lancaster University. It’s hoped the research, which was funded by Alzheimer’s Research UK, could eventually lead to clinical trials to test the compound in people. The study is published in the journal PLoS ONE.